Related Experiment Videos
Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis
Philip L Graham1, Krow Ampofo, Lisa Saiman
1Departments of Pediatrics and Epidemiology, Columbia, University, New York, NY 10032, USA. pgl43@columbia.edu
The Pediatric Infectious Disease Journal
|September 18, 2002
Abstract:
The successful treatment of a 7-month-old infant with shunt-associated ventriculitis caused by vancomycin-resistant Enterococcus faecium is presented. Linezolid was administered intravenously every 8 h; children have a greater volume of distribution and total body clearance than adults and therefore require more frequent dosing. The patient tolerated the therapy without adverse effects.